Literature DB >> 26427904

Orthostatic hypotension: managing a difficult problem.

Pearl K Jones1, Brett H Shaw2, Satish R Raj2,3.   

Abstract

Orthostatic hypotension (OH) leads to a significant number of hospitalizations each year, and is associated with significant morbidity and mortality among affected individuals. Given the increased risk for cardiovascular events and falls, it is important to identify the underlying etiology of OH and to choose appropriate therapeutic agents. OH can be non-neurogenic or neurogenic (arising from a central or peripheral lesion). The initial evaluation includes orthostatic vital signs, complete history and a physical examination. Patients should also be evaluated for concomitant symptoms of post-prandial hypotension and supine hypertension. Non-pharmacologic interventions are the first step for treatment of OH. The appropriate selection of medications can also help with symptomatic relief. This review highlights the pathophysiology, clinical features, diagnostic work-up and treatment of patients with neurogenic OH.

Entities:  

Keywords:  Parkinson’s disease; autonomic failure; autonomic nervous system; droxidopa; multiple system atrophy; orthostatic hypotension; orthostatic intolerance; peripheral neuropathy

Mesh:

Year:  2015        PMID: 26427904      PMCID: PMC4883667          DOI: 10.1586/14779072.2015.1095090

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  79 in total

1.  Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.

Authors:  S Braune; M Reinhardt; R Schnitzer; A Riedel; C H Lücking
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  Midodrine for orthostatic hypotension and recurrent reflex syncope: A systematic review.

Authors:  Ariel Izcovich; Carlos González Malla; Matias Manzotti; Hugo Norberto Catalano; Gordon Guyatt
Journal:  Neurology       Date:  2014-08-22       Impact factor: 9.910

3.  Blood pressure recovery from Valsalva maneuver in patients with autonomic failure.

Authors:  Elizabeth R Vogel; Paola Sandroni; Phillip A Low
Journal:  Neurology       Date:  2005-11-22       Impact factor: 9.910

Review 4.  Current concepts in orthostatic hypotension management.

Authors:  Amy C Arnold; Cyndya Shibao
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 5.  Confounders of vasovagal syncope: orthostatic hypotension.

Authors:  Victor C Nwazue; Satish R Raj
Journal:  Cardiol Clin       Date:  2013-02       Impact factor: 2.213

6.  What is the minimum duration of head-up tilt necessary to detect orthostatic hypotension?

Authors:  Jade A Gehrking; Stacy M Hines; Lisa M Benrud-Larson; Tonette L Opher-Gehrking; Phillip A Low
Journal:  Clin Auton Res       Date:  2005-04       Impact factor: 4.435

7.  Sodium paradoxically reduces the gastropressor response in patients with orthostatic hypotension.

Authors:  Satish R Raj; Italo Biaggioni; Bonnie K Black; Aniket Rali; Jens Jordan; Indu Taneja; Paul A Harris; David Robertson
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

8.  Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.

Authors:  F M Fouad-Tarazi; M Okabe; H Goren
Journal:  Am J Med       Date:  1995-12       Impact factor: 4.965

Review 9.  Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis.

Authors:  Anna Angelousi; Nicolas Girerd; Athanase Benetos; Luc Frimat; Sylvie Gautier; Georges Weryha; Jean-Marc Boivin
Journal:  J Hypertens       Date:  2014-08       Impact factor: 4.844

Review 10.  A systematic review of the pharmacological management of orthostatic hypotension.

Authors:  A C L Ong; P K Myint; L Shepstone; J F Potter
Journal:  Int J Clin Pract       Date:  2013-07       Impact factor: 2.503

View more
  12 in total

1.  Editorial: Autonomic Neuropathy and Cardiovascular Disease in Aging.

Authors:  A Shams; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

2.  Active women demonstrate acute autonomic and hemodynamic shifts following exercise in heat and humidity: A pilot study.

Authors:  Hannah A Zabriskie; Chad M Kerksick; Andrew R Jagim
Journal:  Temperature (Austin)       Date:  2020-08-04

Review 3.  Syncope and Headache.

Authors:  Ramesh K Khurana
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

Review 4.  Orthostatic hypotension for the cardiologist.

Authors:  Philip L Mar; Satish R Raj
Journal:  Curr Opin Cardiol       Date:  2018-01       Impact factor: 2.161

Review 5.  Evaluating the effectiveness of atomoxetine for the treatment of primary orthostatic hypotension in adults.

Authors:  Hetal Patel; Ashley Simpson; Gabrielle Palevoda; Genevieve M Hale
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-22       Impact factor: 3.738

Review 6.  Cardiovascular Disorders Mediated by Autonomic Nervous System Dysfunction.

Authors:  Pravin Khemani; Ali A Mehdirad
Journal:  Cardiol Rev       Date:  2020 Mar/Apr       Impact factor: 3.109

7.  Blood pressure circadian rhythms and adverse outcomes in type 2 diabetes patients diagnosed with orthostatic hypotension.

Authors:  Jing Chang; Yuan-Ping Hou; Jin-Ling Wu; Xiang-Yang Fang; Sheng-Li Li; Miao-Bing Liu; Qian-Mei Sun
Journal:  J Diabetes Investig       Date:  2017-06-21       Impact factor: 4.232

Review 8.  Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.

Authors:  Jeremy K Cutsforth-Gregory; Phillip A Low
Journal:  Neurol Ther       Date:  2019-08-27

Review 9.  Dyspnea in Chronic Low Ventricular Preload States.

Authors:  Rubabin Tooba; Kenneth A Mayuga; Robert Wilson; Adriano R Tonelli
Journal:  Ann Am Thorac Soc       Date:  2021-04

Review 10.  Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls.

Authors:  Peter A LeWitt; Steve Kymes; Robert A Hauser
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.